Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Mar. 25, 2023	Mar. 26, 2022
Operating activities:
Net earnings	$ 13,504	$ 14,362
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation of fixed assets	27,236	23,868
Amortization of intangibles and deferred costs	3,385	1,183
Gain (loss) from disposals of property & equipment	(354)	100
Share-based compensation	2,552	2,350
Deferred income taxes	(787)	(251)
(Gain) loss on marketable securities	(22)	69
Other	(255)	(184)
Changes in assets and liabilities, net of effects from purchase of companies
Decrease (increase) in accounts receivable	10,541	(25,031)
Decrease (increase) in inventories	823	(36,538)
Decrease (increase) in prepaid expenses	4,787	(4,308)
(Decrease) in accounts payable and accrued liabilities	(25,739)	(2,055)
Net cash provided by (used in) operating activities	35,671	(26,435)
Investing activities:
Purchases of property, plant and equipment	(49,124)	(35,306)
Proceeds from redemption and sales of marketable securities	5,300	11,526
Proceeds from disposal of property and equipment	797	589
Net cash (used in) investing activities	(43,027)	(23,191)
Financing activities:
Proceeds from issuance of stock	4,059	11,741
Borrowings under credit facility	92,000	0
Repayment of borrowings under credit facility	(55,000)	0
Payments on finance lease obligations	(71)	(111)
Payment of cash dividend	(26,914)	(24,163)
Net cash provided by (used in) financing activities	14,074	(12,533)
Effect of exchange rates on cash and cash equivalents	1,384	(16)
Net increase (decrease) in cash and cash equivalents	8,102	(62,175)
Cash and cash equivalents at beginning of period	35,181	283,192
Cash and cash equivalents at end of period	$ 43,283	$ 221,017